Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus

The valid period of PRRSFREE PRRS subunit vaccine has been extend from 24 months to 36 months

Reber eyes new markets and vaccines